32 research outputs found
Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model
The identification of microbial biomarkers is critical for the diagnosis of a disease early during infection. However, the identification of reliable biomarkers is often hampered by a low concentration of microbes or biomarkers within host fluids or tissues. We have outlined a multi-platform strategy to assess microbial biomarkers that can be consistently detected in host samples, using Borrelia burgdorferi, the causative agent of Lyme disease, as an example. Key aspects of the strategy include the selection of a macaque model of human disease, in vivo Microbial Antigen Discovery (InMAD), and proteomic methods that include microbial biomarker enrichment within samples to identify secreted proteins circulating during infection. Using the described strategy, we have identified 6 biomarkers from multiple samples. In addition, the temporal antibody response to select bacterial antigens was mapped. By integrating biomarkers identified from early infection with temporal patterns of expression, the described platform allows for the data driven selection of diagnostic targets
The Functional and Molecular Effects of Doxycycline Treatment on Borrelia burgdorferi Phenotype
Recent studies have shown that Borrelia burgdorferi can form antibiotic-tolerant persisters in the presence of microbiostatic drugs such as doxycycline. Precisely how this occurs is yet unknown. Our goal was to examine gene transcription by B. burgdorferi following doxycycline treatment in an effort to identify both persister-associated genes and possible targets for antimicrobial intervention. To do so, we performed next-generation RNA sequencing on doxycycline-treated spirochetes and treated spirochetes following regrowth, comparing them to untreated B. burgdorferi. A number of genes were perturbed and most of those which were statistically significant were down-regulated in the treated versus the untreated or treated/re-grown. Genes upregulated in the treated B. burgdorferi included a number of Erp genes and rplU, a 50S ribosomal protein. Among those genes associated with post-treatment regrowth were bba74 (Oms28), bba03, several peptide ABC transporters, ospA, ospB, ospC, dbpA and bba62. Studies are underway to determine if these same genes are perturbed in B. burgdorferi treated with doxycycline in a host environment
Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease
Lyme disease (LD) results from the most prevalent tick-borne infection in North America, with over 476,000 estimated cases annually. The disease is caused by Borrelia burgdorferi (Bb) sensu lato which transmits through the bite of Ixodid ticks. Most cases treated soon after infection are resolved by a short course of oral antibiotics. However, 10–20% of patients experience chronic symptoms because of delayed or incomplete treatment, a condition called Post-Treatment Lyme Disease (PTLD). Some Bb persists in PTLD patients after the initial course of antibiotics and an effective treatment to eradicate the persistent Bb is needed. Other organisms that cause persistent infections, such as M. tuberculosis, are cleared using a combination of therapies rather than monotherapy. A group of Food and Drug Administration (FDA)-approved drugs previously shown to be efficacious against Bb in vitro were used in monotherapy or in combination in mice infected with Bb. Different methods of detection were used to assess the efficacy of the treatments in the infected mice including culture, xenodiagnosis, and molecular techniques. None of the monotherapies eradicated persistent Bb. However, 4 dual combinations (doxycycline + ceftriaxone, dapsone + rifampicin, dapsone + clofazimine, doxycycline + cefotaxime) and 3 triple combinations (doxycycline + ceftriaxone+ carbomycin, doxycycline + cefotaxime+ loratadine, dapsone+ rifampicin+ clofazimine) eradicated persistent Bb infections. These results suggest that combination therapy should be investigated in preclinical studies for treating human Lyme disease
Amblyomma maculatum Feeding Augments Rickettsia parkeri Infection in a Rhesus Macaque Model: A Pilot Study.
Rickettsia parkeri is an emerging eschar-causing human pathogen in the spotted fever group of Rickettsia and is transmitted by the Gulf coast tick, Amblyomma maculatum. Tick saliva has been shown to alter both the cellular and humoral components of the innate and adaptive immune systems. However, the effect of this immunomodulation on Rickettsia transmission and pathology in an immunocompetent vertebrate host has not been fully examined. We hypothesize that, by modifying the host immune response, tick feeding enhances infection and pathology of pathogenic spotted fever group Rickettsia sp. In order to assess this interaction in vivo, a pilot study was conducted using five rhesus macaques that were divided into three groups. One group was intradermally inoculated with low passage R. parkeri (Portsmouth strain) alone (n = 2) and another group was inoculated during infestation by adult, R. parkeri-free A. maculatum (n = 2). The final macaque was infested with ticks alone (tick feeding control group). Blood, lymph node and skin biopsies were collected at several time points post-inoculation/infestation to assess pathology and quantify rickettsial DNA. As opposed to the tick-only animal, all Rickettsia-inoculated macaques developed inflammatory leukograms, elevated C-reactive protein concentrations, and elevated TH1 (interferon-γ, interleukin-15) and acute phase inflammatory cytokines (interleukin-6) post-inoculation, with greater neutrophilia and interleukin-6 concentrations in the tick plus R. parkeri group. While eschars formed at all R. parkeri inoculation sites, larger and slower healing eschars were observed in the tick feeding plus R. parkeri group. Furthermore, dissemination of R. parkeri to draining lymph nodes early in infection and increased persistence at the inoculation site were observed in the tick plus R. parkeri group. This study indicates that rhesus macaques can be used to model R. parkeri rickettsiosis, and suggests that immunomodulatory factors introduced during tick feeding may enhance the pathogenicity of spotted fever group Rickettsia
Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease
The systematically difficult task of diagnosing Lyme disease can be simplified by sensitive and specific laboratory tests. The currently recommended two-tier test for serology is highly specific but falls short in sensitivity, especially in the early acute phase. We previously examined serially collected serum samples from Borrelia burgdorferi-infected rhesus macaques and defined a combination of antigens that could be utilized for detection of infection at all phases of disease in humans. The five B. burgdorferi antigens, consisting of OspC, OspA, DbpA, OppA2, and the C6 peptide, were combined into a fluorescent cytometric bead-based assay for the detection of B. burgdorferi antigen-specific IgG antibodies. Samples from Lyme disease patients and controls were used to determine the diagnostic value of this assay. Using this sample set, we found that our five-antigen multiplex IgG assay exhibited higher sensitivity (79.5%) than the enzyme immunoassay (EIA) (76.1%), the two-tier test (61.4%), and the C6 peptide enzyme-linked immunosorbent assay (ELISA) (77.2%) while maintaining specificity over 90%. When detection of IgM was added to the bead-based assay, the sensitivity improved to 91%, but at a cost of reduced specificity (78%). These results indicate that the rational combination of antigens in our multiplex assay may offer an improved serodiagnostic test for Lyme disease
Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease
The systematically difficult task of diagnosing Lyme disease can be simplified by sensitive and specific laboratory tests. The currently recommended two-tier test for serology is highly specific but falls short in sensitivity, especially in the early acute phase. We previously examined serially collected serum samples from Borrelia burgdorferi-infected rhesus macaques and defined a combination of antigens that could be utilized for detection of infection at all phases of disease in humans. The five B. burgdorferi antigens, consisting of OspC, OspA, DbpA, OppA2, and the C6 peptide, were combined into a fluorescent cytometric bead-based assay for the detection of B. burgdorferi antigen-specific IgG antibodies. Samples from Lyme disease patients and controls were used to determine the diagnostic value of this assay. Using this sample set, we found that our five-antigen multiplex IgG assay exhibited higher sensitivity (79.5%) than the enzyme immunoassay (EIA) (76.1%), the two-tier test (61.4%), and the C6 peptide enzyme-linked immunosorbent assay (ELISA) (77.2%) while maintaining specificity over 90%. When detection of IgM was added to the bead-based assay, the sensitivity improved to 91%, but at a cost of reduced specificity (78%). These results indicate that the rational combination of antigens in our multiplex assay may offer an improved serodiagnostic test for Lyme disease
Anti-<i>Rickettsia</i> immunohistochemistry demonstrating numerous organisms in the skin of animals inoculated with <i>R</i>. <i>parkeri</i> at 4 dpi as opposed to rare <i>Rickettsia</i> in the tick-only animal.
<p>Photomicrographs of skin sections stained with a polyclonal anti-<i>Rickettsia</i> antibody at 4 dpi. (A) Rare cells contain positive, brown-staining, rickettsial organisms in the tick-only animal. (B) Abundant positive, brown-staining, organisms in a section from an animal in the <i>R</i>. <i>parkeri</i>-only group. (C) Similarly, many organisms are noted in an animal from the tick + <i>R</i>. <i>parkeri</i> group. The red-framed images at the bottom are higher magnification views of the red-boxed areas in the top images. Black-framed insets are higher magnification images of the black-boxed areas and highlight the coccobacilli morphology of the positively stained rickettsial organisms.</p
Evidence of an acute phase inflammatory response in response to <i>R</i>. <i>parkeri</i> inoculation.
<p>Comparisons of neutrophil (A), lymphocyte (B), and C-reactive protein (C) concentrations in peripheral blood of all animals at the various time points indicated. Neutrophilia, lymphopenia, and elevated C-reactive protein were noted in the acute phase of infection after <i>R</i>. <i>parkeri</i> inoculation with greater neutrophilia noted in the tick + <i>R</i>. <i>parkeri</i> group. For presentation purposes all of the final time points are plotted as 31 dpi as opposed to 31, 32, and 35 dpi for the tick-only, tick feeding + <i>R</i>. <i>parkeri</i>, and <i>R</i>. <i>parkeri</i>-only groups, respectively.</p
Experimental design for tick feeding, <i>R</i>. <i>parkeri</i>/Vero cell inoculation, and sample collection.
<p>Adult <i>Amblyomma maculatum</i> ticks were placed on the hosts as indicated. Either a partially purified low passage human isolate of <i>R</i>. <i>parkeri</i> or an uninfected Vero cell inoculum was administered at the indicated time points. Blood collection, physical exams (PE), rectal temperatures, and skin and lymph node biopsies were taken from all animals at the indicated time points. Complete necropsies were performed at the end of the study as indicated.</p
Concentrations of serum inflammatory cytokines are increased in response to <i>R</i>. <i>parkeri</i> inoculation.
<p>Comparisons of interleukin-6 (D), interferon γ (E), and interleukin-15 (F) concentrations in serum of all animals at the various indicated time points as determined by a magnetic cytokine bead panel kit. Measurements were performed in duplicate with the bars indicating standard error. For presentation purposes all of the final time points are plotted as 31 dpi as opposed to 31, 32, and 35 dpi for the tick-only, tick feeding + <i>R</i>. <i>parkeri</i>, and <i>R</i>. <i>parkeri</i>-only groups, respectively.</p